AAAAAA

   
Results: 1-16 |
Results: 16
MOUSE MAMMARY-CARCINOMA CELL-LINE (BALB C-MC) STIMULATES OSTEOCLAST FORMATION FROM MOUSE BONE-MARROW CELLS THROUGH CELL-TO-CELL CONTACT/
Authors: ONO K AKATSU T MURAKAMI T WADA S NISHIKAWA M KUGAI N YAMAMOTO M MATSUURA N NAGATA N
Citation: K. Ono et al., MOUSE MAMMARY-CARCINOMA CELL-LINE (BALB C-MC) STIMULATES OSTEOCLAST FORMATION FROM MOUSE BONE-MARROW CELLS THROUGH CELL-TO-CELL CONTACT/, Bone, 23(1), 1998, pp. 27-32
CHINESE-HAMSTER OVARY CELLS EXPRESSING ALPHA(4)BETA(1) INTEGRIN STIMULATE OSTEOCLAST FORMATION IN-VITRO
Authors: AKATSU T ONO K MURAKAMI T KATAYAMA Y NISHIKAWA M WADA S YAMAMOTO M KUGAI N MATSUURA N TAKADA Y NAGATA N
Citation: T. Akatsu et al., CHINESE-HAMSTER OVARY CELLS EXPRESSING ALPHA(4)BETA(1) INTEGRIN STIMULATE OSTEOCLAST FORMATION IN-VITRO, Journal of bone and mineral research, 13(8), 1998, pp. 1251-1259
A 3RD-GENERATION BISPHOSPHONATE, YM175, INHIBITS OSTEOCLAST FORMATIONIN MURINE COCULTURES BY INHIBITING PROLIFERATION OF PRECURSOR CELLS VIA SUPPORTING CELL-DEPENDENT MECHANISMS
Authors: NISHIKAWA M YAMAMOTO M MURAKAMI T AKATSU T KUGAI N NAGATA N
Citation: M. Nishikawa et al., A 3RD-GENERATION BISPHOSPHONATE, YM175, INHIBITS OSTEOCLAST FORMATIONIN MURINE COCULTURES BY INHIBITING PROLIFERATION OF PRECURSOR CELLS VIA SUPPORTING CELL-DEPENDENT MECHANISMS, Journal of bone and mineral research, 13(6), 1998, pp. 986-995
THE MOUSE MAMMARY-TUMOR CELL-LINE, MMT060562, PRODUCES PROSTAGLANDIN E-2 AND LEUKEMIA INHIBITORY FACTOR AND SUPPORTS OSTEOCLAST FORMATION IN-VITRO VIA A STROMAL CELL-DEPENDENT PATHWAY
Authors: AKATSU T ONO K KATAYAMA Y TAMURA T NISHIKAWA M KUGAI N YAMAMOTO M NAGATA N
Citation: T. Akatsu et al., THE MOUSE MAMMARY-TUMOR CELL-LINE, MMT060562, PRODUCES PROSTAGLANDIN E-2 AND LEUKEMIA INHIBITORY FACTOR AND SUPPORTS OSTEOCLAST FORMATION IN-VITRO VIA A STROMAL CELL-DEPENDENT PATHWAY, Journal of bone and mineral research, 13(3), 1998, pp. 400-408
IMPORTANT ROLE OF EP4, A SUBTYPE OF PROSTAGLANDIN (PG)-E RECEPTOR, INOSTEOCLAST-LIKE CELL-FORMATION FROM MOUSE BONE-MARROW CELLS INDUCED BY PGE(2)
Authors: ONO K AKATSU T MURAKAMI T NISHIKAWA M YAMAMOTO M KUGAI N MOTOYOSHI K NAGATA N
Citation: K. Ono et al., IMPORTANT ROLE OF EP4, A SUBTYPE OF PROSTAGLANDIN (PG)-E RECEPTOR, INOSTEOCLAST-LIKE CELL-FORMATION FROM MOUSE BONE-MARROW CELLS INDUCED BY PGE(2), Journal of Endocrinology, 158(3), 1998, pp. 1-5
LACK OF ASSOCIATION BETWEEN THE TRP(64)ARG MUTATION IN THE BETA(3)-ADRENERGIC RECEPTOR GENE AND OBESITY JAPANESE MEN - A LONGITUDINAL ANALYSIS
Authors: NAGASE T AOKI A YAMAMOTO M YASUDA H KADO S NISHIKAWA M KUGAI N AKATSU T NAGATA N
Citation: T. Nagase et al., LACK OF ASSOCIATION BETWEEN THE TRP(64)ARG MUTATION IN THE BETA(3)-ADRENERGIC RECEPTOR GENE AND OBESITY JAPANESE MEN - A LONGITUDINAL ANALYSIS, The Journal of clinical endocrinology and metabolism, 82(4), 1997, pp. 1284-1287
BISPHOSPHONATES ACT ON OSTEOBLASTIC CELLS AND INHIBIT OSTEOCLAST FORMATION IN MOUSE MARROW CULTURES
Authors: NISHIKAWA M AKATSU T KATAYAMA Y YASUTOMO Y KADO S KUGAI N YAMAMOTO M NAGATA N
Citation: M. Nishikawa et al., BISPHOSPHONATES ACT ON OSTEOBLASTIC CELLS AND INHIBIT OSTEOCLAST FORMATION IN MOUSE MARROW CULTURES, Bone, 18(1), 1996, pp. 9-14
ROLE OF NONENZYMATIC GLYCOSYLATION OF TYPE-I COLLAGEN IN DIABETIC OSTEOPENIA
Authors: KATAYAMA Y AKATSU T YAMAMOTO M KUGAI N NAGATA N
Citation: Y. Katayama et al., ROLE OF NONENZYMATIC GLYCOSYLATION OF TYPE-I COLLAGEN IN DIABETIC OSTEOPENIA, Journal of bone and mineral research, 11(7), 1996, pp. 931-937
DIVERSITY OF MECHANISM OF OSTEOCLAST INDUCTION BY TUMOR-CELLS IN-VITRO
Authors: AKATSU T ONO K WADA S NISHIKAWA M KUGAI N YAMAMOTO M NAGATA N MATSUURA N
Citation: T. Akatsu et al., DIVERSITY OF MECHANISM OF OSTEOCLAST INDUCTION BY TUMOR-CELLS IN-VITRO, Journal of bone and mineral research, 11, 1996, pp. 410-410
URINARY TYPE-IV COLLAGEN AS A MARKER FOR EARLY DIABETIC NEPHROPATHY
Authors: KADO S AOKI A WADA S KATAYAMA Y KUGAI N YOSHIZAWA N NAGATA N
Citation: S. Kado et al., URINARY TYPE-IV COLLAGEN AS A MARKER FOR EARLY DIABETIC NEPHROPATHY, Diabetes research and clinical practice, 31(1-3), 1996, pp. 103-108
MAGNETIC-RESONANCE-IMAGING OF MULTIPLE BRAIN ABSCESSES OF THE BILATERAL BASAL GANGLIA
Authors: NAGASE T WADA S NAKAMURA R MORISAKO T KAMAKURA K KUGAI N YAMAMOTO M TSUCHIYA K NAGATA N
Citation: T. Nagase et al., MAGNETIC-RESONANCE-IMAGING OF MULTIPLE BRAIN ABSCESSES OF THE BILATERAL BASAL GANGLIA, Internal medicine, 34(6), 1995, pp. 554-558
NON-CUSHINGOID CUSHINGS-SYNDROME DUE TO ADRENOCORTICOTROPIC HORMONE-INDEPENDENT BILATERAL ADRENOCORTICAL MACRONODULAR HYPERPLASIA
Authors: NEMOTO Y AOKI A KATAYAMA Y KADO S YASUTOMO Y KUGAI N YAMAMOTO M TERAHATA S NAGATA N
Citation: Y. Nemoto et al., NON-CUSHINGOID CUSHINGS-SYNDROME DUE TO ADRENOCORTICOTROPIC HORMONE-INDEPENDENT BILATERAL ADRENOCORTICAL MACRONODULAR HYPERPLASIA, Internal medicine, 34(5), 1995, pp. 446-450
ROLE OF NONENZYMATIC GLYCATION OF TYPE-1 COLLAGEN IN DIABETIC OSTEOPENIA
Authors: KATAYAMA Y YAMAMOTO M AKATSU T KADO S MURAKAMI T NAGASE T YASUTOMO Y KUGAI N NAGATA N
Citation: Y. Katayama et al., ROLE OF NONENZYMATIC GLYCATION OF TYPE-1 COLLAGEN IN DIABETIC OSTEOPENIA, Journal of bone and mineral research, 10, 1995, pp. 411-411
A CASE OF 17-ALPHA-HYDROXYLASE DEFICIENCY WITH RETAINED MENSTRUATION
Authors: KATAYAMA Y KADO S WADA S NEMOTO Y KUGAI N FURUYA K NAGATA N
Citation: Y. Katayama et al., A CASE OF 17-ALPHA-HYDROXYLASE DEFICIENCY WITH RETAINED MENSTRUATION, Endocrine journal, 41(2), 1994, pp. 213-218
THYROID-DYSFUNCTION IN ISOLATED ADRENOCORTICOTROPIC HORMONE (ACTH) DEFICIENCY - CASE-REPORT AND LITERATURE-REVIEW
Authors: MURAKAMI T WADA S KATAYAMA Y NEMOTO Y KUGAI N NAGATA N
Citation: T. Murakami et al., THYROID-DYSFUNCTION IN ISOLATED ADRENOCORTICOTROPIC HORMONE (ACTH) DEFICIENCY - CASE-REPORT AND LITERATURE-REVIEW, Endocrine journal, 40(4), 1993, pp. 473-478
CHANGES OF BONE METABOLIC MARKERS IN PATIENTS WITH BONE METASTASES - CLINICAL-SIGNIFICANCE IN ASSESSING BONE RESPONSE TO CHEMOTHERAPY
Authors: WADA S KATAYAMA Y YASUTOMO Y KUGAI N NAGATA N
Citation: S. Wada et al., CHANGES OF BONE METABOLIC MARKERS IN PATIENTS WITH BONE METASTASES - CLINICAL-SIGNIFICANCE IN ASSESSING BONE RESPONSE TO CHEMOTHERAPY, Internal medicine, 32(8), 1993, pp. 611-618
Risultati: 1-16 |